dronabinol has been researched along with Innate Inflammatory Response in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.26) | 18.2507 |
| 2000's | 10 (21.28) | 29.6817 |
| 2010's | 25 (53.19) | 24.3611 |
| 2020's | 10 (21.28) | 2.80 |
| Authors | Studies |
|---|---|
| Britch, SC; Craft, RM | 1 |
| Gehlsen, U; Maass, M; Musial, G; Stern, ME; Steven, P; Tran, BN | 1 |
| D'Aquila, RT; McDade, TW; Mustanski, B; Schrock, JM | 1 |
| Ghasemi Gojani, E; Ilnytskyy, Y; Kovalchuk, I; Kovalchuk, O; Li, D | 1 |
| Nguyen, T | 1 |
| Costiniuk, CT; Jenabian, MA | 1 |
| Cairns, EA; Kelly, MEM; Kulkarni, PM; Straiker, AJ; Szczesniak, AM; Thakur, GA; Thapa, D | 1 |
| Dyck, JRB; Ferdaoussi, M; Maayah, ZH; Takahara, S | 1 |
| Ashpole, NM; Faruque, AS; Lovitt, KG; Pandelides, Z; Thornton, C; Whitehead, AP; Willett, KL | 1 |
| Hellman, J; Joffre, J; Kobzik, L; Legrand, M; Lloyd, E; Thete, M; Wong, E; Xu, F; Yeh, CC; Zlatanova, I | 1 |
| Cooray, R; Gupta, V; Suphioglu, C | 1 |
| Bitencourt, RM; Cavalheiro, EKFF; Costa, AB; Mendes, TF; Rezin, GT; Salla, DH; Silva, LED; Silva, MRD; Turatti, CDR | 1 |
| MacCallum, CA; Russo, EB | 1 |
| Cheu, RK; Collier, AC; Coronado, E; Funderburg, NT; Gott, TM; Hensley-McBain, T; Hunt, PW; Isoherranen, N; Kirkwood, JS; Klatt, NR; Manuzak, JA; Martin, JN; Miller, C; Wu, MC | 1 |
| Burstein, SH | 1 |
| Limebeer, CL; Parker, LA; Rock, EM | 1 |
| Beydogan, AB; Bolkent, S; Coskun, ZM | 1 |
| Almogi-Hazan, O; Khuja, I; Or, R; Yekhtin, Z | 1 |
| Al-Ghezi, ZZ; Alghetaa, H; Busbee, PB; Nagarkatti, M; Nagarkatti, PS | 1 |
| Ben-Nun, A; Juknat, A; Kaushansky, N; Kozela, E; Rimmerman, N; Vogel, Z | 1 |
| Cabral, GA; Jamerson, M; Marciano-Cabral, F; Raborn, ES | 1 |
| Amedee, A; Chandra, LC; Kumar, V; Mohan, M; Molina, PE; Torben, W; Vande Stouwe, C; Winsauer, P | 1 |
| Ding, Y; Han, YC; Jia, B; Li, FF; Yang, L | 1 |
| Nagarkatti, M; Nagarkatti, PS; Sido, JM | 1 |
| Bao, Q; Hu, N; Jiang, L; Xiao, D; Xie, J; Yu, L; Zhao, J | 1 |
| Kinsey, SG; Lichtman, AH; Schlosburg, JE | 1 |
| Burstein, SH; Zurier, RB | 1 |
| Juknat, A; Kozela, E; Levy, R; Pietr, M; Rimmerman, N; Vogel, Z | 1 |
| Bolognini, D; Cascio, MG; Comelli, F; Costa, B; Di Marzo, V; Gauson, LA; Maione, S; Marini, P; Parolaro, D; Pertwee, RG; Ross, RA | 1 |
| Jamontt, JM; Molleman, A; Parsons, ME; Pertwee, RG | 1 |
| DeLong, GT; Lichtman, AH; Poklis, A; Wolf, CE | 1 |
| Amere, M; Bátkai, S; Battista, N; Gao, RY; Gauson, LA; Horváth, B; Lichtman, AH; Maccarrone, M; Mahadevan, A; Mukhopadhyay, P; Pacher, P; Pertwee, RG; Rajesh, M | 1 |
| Aviello, G; De Petrocellis, L; Di Marzo, V; Izzo, AA; Moriello, AS; Orlando, P; Stott, C | 1 |
| Haskó, G; Horváth, B; Mukhopadhyay, P; Pacher, P | 1 |
| Fernández-Ruiz, J; Pertwee, RG; Sagredo, O; Satta, V; Valdeolivas, S | 1 |
| Di Marzo, V; Skaper, SD | 1 |
| Chen, W; Crawford, R; Kaminski, NE; Kaplan, BL; Karmaus, PW | 1 |
| Roth, MD | 1 |
| Arnaud, C; Burger, F; Frossard, JL; Karsak, M; Mach, F; Pelli, G; Staub, C; Steffens, S; Veillard, NR; Zimmer, A | 1 |
| Aslan, S; Mitchell, VA; Safaei, R; Vaughan, CW | 1 |
| Brain, C; Chen, A; Courade, JP; Dyson, A; Fox, A; Groarke, A; Loong, Y; Peacock, M; Yaqoob, M | 1 |
| Chapman, V; Clayton, NM; Elmes, SJR; Kendall, DA; Medhurst, SJ; Wilson, AW; Winyard, LA | 1 |
| Buchweitz, JP; Harkema, JR; Kaminski, NE; Karmaus, PW; Williams, KJ | 2 |
| James, JS | 1 |
| Colleoni, M; Conti, S; Costa, B; Giagnoni, G; Parolaro, D | 1 |
| Evans, FJ | 1 |
10 review(s) available for dronabinol and Innate Inflammatory Response
| Article | Year |
|---|---|
Cannabinoids and inflammation: implications for people living with HIV.
Topics: Animals; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dronabinol; HIV Infections; Humans; Inflammation; Lymphocyte Activation; Macaca mulatta; Randomized Controlled Trials as Topic; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus | 2019 |
The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Inflammation; Neuralgia; Plant Extracts | 2020 |
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
Topics: Alzheimer Disease; Animals; Cannabidiol; Dronabinol; Endocannabinoids; Humans; Inflammation; Parkinson Disease | 2020 |
Topics: Analgesics; Anti-Inflammatory Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Humans; Inflammation; Obesity | 2022 |
Practical considerations in medical cannabis administration and dosing.
Topics: Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Combinations; Humans; Inflammation; Medical Marijuana; Pain | 2018 |
Ajulemic acid: potential treatment for chronic inflammation.
Topics: Animals; Chronic Disease; Clinical Trials as Topic; Dronabinol; Drug Evaluation, Preclinical; Humans; Inflammation; Treatment Outcome | 2018 |
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
Topics: Amidohydrolases; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Disease Models, Animal; Dronabinol; Drug Delivery Systems; Drug Evaluation, Preclinical; Endocannabinoids; Glycerides; Humans; Inflammation; Mice; Mice, Knockout; Pain; Peroxisome Proliferator-Activated Receptors; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Opioid; TRPV Cation Channels | 2009 |
Cannabinoids, endocannabinoids, and related analogs in inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Cannabis; Disease Models, Animal; Dronabinol; Drug Evaluation, Preclinical; Eicosanoids; Endocannabinoids; Fibromyalgia; Glycine; Humans; Inflammation; Mice; Plant Oils; Randomized Controlled Trials as Topic; Rats; Receptors, Cannabinoid | 2009 |
The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.
Topics: Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Cannabinoids; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dronabinol; Endocannabinoids; Humans; Inflammation; Oxidative Stress | 2012 |
Cannabinoids: the separation of central from peripheral effects on a structural basis.
Topics: Animals; Cannabinoids; Central Nervous System; Dronabinol; Humans; Inflammation; Pain; Peripheral Nerves; Structure-Activity Relationship | 1991 |
37 other study(ies) available for dronabinol and Innate Inflammatory Response
| Article | Year |
|---|---|
No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Freund's Adjuvant; Hyperalgesia; Inflammation; Locomotion; Male; Morphine; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sex Factors | 2021 |
Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease.
Topics: Animals; Cannabinoids; Cornea; Dronabinol; Dry Eye Syndromes; Endocannabinoids; Inflammation; Ligands; Mice; Mice, Inbred C57BL; Tears | 2022 |
Does body mass index explain the apparent anti-inflammatory effects of cannabis use? Results From a cohort study of sexual and gender minority youth.
Topics: Adolescent; Anti-Inflammatory Agents; Biomarkers; Body Mass Index; C-Reactive Protein; Cannabinoid Receptor Agonists; Cannabis; Cohort Studies; Dronabinol; Hallucinogens; HIV Infections; Humans; Infant, Newborn; Inflammation; Interleukin-6; Male; Sexual and Gender Minorities | 2022 |
Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.
Topics: Anti-Inflammatory Agents; Camphor; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cyclooxygenase 2; Cymenes; Dronabinol; Eucalyptol; Hallucinogens; Humans; Inflammation; Interleukin-6; Plant Extracts; Terpenes; Tumor Necrosis Factor-alpha | 2022 |
Working out with weed.
Topics: Adult; Arachidonic Acids; Athletic Performance; Cannabidiol; Cannabis; Doping in Sports; Dronabinol; Endocannabinoids; Exercise; Female; Humans; Inflammation; Male; Marijuana Use; Motivation; Performance-Enhancing Substances; Polyunsaturated Alkamides; Reproducibility of Results; Young Adult | 2019 |
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
Topics: Allosteric Regulation; Animals; Cautery; Corneal Injuries; Disease Models, Animal; Dronabinol; Drug Synergism; Gene Knockout Techniques; Hyperalgesia; Indoles; Inflammation; Ligands; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2020 |
Developmental exposure to Δ
Topics: Animals; Dronabinol; Inflammation; Longevity; Male; Reproduction; Zebrafish | 2020 |
Activation of CB
Topics: Animals; Bodily Secretions; Cannabinoid Receptor Agonists; Cannabinoids; Cytokines; Dronabinol; Endocannabinoids; Female; Inflammation; Interleukin-10; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Monocytes; Myeloid-Derived Suppressor Cells; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Signal Transduction; Spleen | 2020 |
Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dronabinol; Female; Flow Cytometry; HIV Infections; Humans; Immunity, Innate; Inflammation; Lymphocyte Activation; Male; Marijuana Abuse; Middle Aged; Monocytes; Viral Load | 2018 |
Effect of cannabidiolic acid and ∆
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Cannabinoids; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Edema; Hyperalgesia; Inflammation; Male; Pain; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2018 |
The protective effects of Δ
Topics: Animals; Blood Glucose; Body Weight; Dronabinol; Fructose; Glutathione; Hyperinsulinism; Inflammation; Insulin; Insulin Resistance; Liver; Male; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley | 2019 |
Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation.
Topics: Animals; Bone Marrow Transplantation; Cannabidiol; Disease Models, Animal; Dronabinol; Female; Graft vs Host Disease; Inflammation; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Treatment Outcome | 2019 |
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Cytokines; Disease Models, Animal; Dronabinol; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Female; Gastrointestinal Microbiome; Inflammation; Interferon-gamma; Interleukin-17; Mice; Mice, Inbred C57BL; Multiple Sclerosis; RNA, Ribosomal, 16S | 2019 |
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Topics: Animals; Antigen-Presenting Cells; Cannabidiol; Cell Line; Coculture Techniques; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Inflammation; Interferon-gamma; Interleukin-17; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Th17 Cells; Tumor Necrosis Factor-alpha | 2013 |
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.
Topics: Blood-Brain Barrier; Cannabinoid Receptor Agonists; Cell Adhesion; Collagen Type IV; Cyclohexanols; Dronabinol; Extracellular Matrix; Extracellular Matrix Proteins; HIV-1; Humans; Inflammation; Laminin; Monocytes; Receptor, Cannabinoid, CB2; Recombinant Proteins; tat Gene Products, Human Immunodeficiency Virus; U937 Cells | 2014 |
Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques.
Topics: Animals; Anti-Inflammatory Agents; Dronabinol; Gastrointestinal Tract; Gene Expression Profiling; Inflammation; Macaca mulatta; Male; MicroRNAs; Simian Immunodeficiency Virus; Time Factors | 2015 |
Cannabinoid receptor CB2 is involved in tetrahydrocannabinol-induced anti-inflammation against lipopolysaccharide in MG-63 cells.
Topics: Cell Line, Tumor; Dronabinol; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Interleukin-8; Lipopolysaccharides; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha | 2015 |
Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.
Topics: Adoptive Transfer; Animals; Cell Proliferation; Cytokines; Dronabinol; Female; Graft Rejection; Graft Survival; Graft vs Host Reaction; Immune Tolerance; Inflammation; Inflammation Mediators; Lymph Nodes; Lymphocyte Activation; Mice, Inbred C57BL; Myeloid Cells; Receptor, Cannabinoid, CB1; Skin Transplantation; Transplantation, Homologous | 2015 |
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cell Line; Dronabinol; Drug Carriers; Drug Delivery Systems; Hyperalgesia; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Nanoparticles; Neuralgia; Oligopeptides; Oxidation-Reduction; Pain Management; Silicon Dioxide | 2016 |
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Topics: Animals; Cannabidiol; Cell Line; Cell Survival; Dronabinol; Inflammation; Intercellular Signaling Peptides and Proteins; Interferon-beta; Intracellular Space; Lipopolysaccharides; Mice; Microglia; NF-kappa B; STAT Transcription Factors | 2010 |
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.
Topics: Animals; Cell Line, Transformed; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Dronabinol; Edema; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Inflammation; Male; Membranes; Mice; Mice, Inbred C57BL; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spleen | 2010 |
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Topics: Animals; Cannabidiol; Colitis; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Gastrointestinal Motility; In Vitro Techniques; Inflammation; Male; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2010 |
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoids; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Hypothermia; Inflammation; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2010 |
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
Topics: Alanine Transaminase; Aldehydes; Animals; Apoptosis; Aspartate Aminotransferases; CHO Cells; Cricetinae; Cricetulus; Cytokines; DNA Fragmentation; Dronabinol; Humans; Inflammation; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Receptor, Cannabinoid, CB2; Reperfusion Injury; RNA, Messenger | 2012 |
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.
Topics: Animals; Calcium; Cannabidiol; Cannabinoids; Dronabinol; Gastrointestinal Diseases; HEK293 Cells; Humans; Inflammation; Intestine, Small; Mice; Rats; TRPV Cation Channels | 2012 |
Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Topics: Animals; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Combinations; Drug Therapy, Combination; Huntington Disease; Inflammation; Male; Malonates; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
Endocannabinoids in nervous system health and disease: the big picture in a nutshell.
Topics: Arachidonic Acids; Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dronabinol; Electrical Synapses; Endocannabinoids; Glycerides; Humans; Inflammation; Neurodegenerative Diseases; Neurogenesis; Neuroprotective Agents; Nociceptors; Polyunsaturated Alkamides; Receptors, Cannabinoid; Synaptic Transmission | 2012 |
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.
Topics: Animals; Bronchoalveolar Lavage Fluid; Coculture Techniques; Dronabinol; Flow Cytometry; Humans; Inflammation; Influenza, Human; Mice; Mice, Inbred C57BL; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2013 |
Pharmacology: marijuana and your heart.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Chemotaxis, Leukocyte; Dronabinol; Humans; Inflammation; Macrophages; Mice; Receptor, Cannabinoid, CB2; Receptors, CCR2; Receptors, Chemokine | 2005 |
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Cells, Cultured; Chemotaxis, Leukocyte; Disease Models, Animal; Disease Progression; Dronabinol; Humans; Inflammation; Interferon-gamma; Macrophages; Mice; Mice, Knockout; Receptor, Cannabinoid, CB2; Receptors, CCR2; Receptors, Chemokine; RNA, Messenger; Survival Rate; Th1 Cells; Thioglycolates; Tumor Necrosis Factor-alpha | 2005 |
Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dronabinol; Excitatory Amino Acid Antagonists; Inflammation; Ligation; Male; Motor Activity; Neuralgia; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2005 |
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Catalepsy; Cell Line; Chromatography; Cricetinae; Cricetulus; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Freund's Adjuvant; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypothermia; Inflammation; Ligation; Male; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Sciatic Neuropathy; Sulfur Isotopes; Time Factors; Tritium | 2005 |
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
Topics: Analgesics; Animals; Cannabinoids; Carrageenan; Dronabinol; Drug Combinations; Hyperalgesia; Inflammation; Male; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome; Weight-Bearing | 2005 |
Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice.
Topics: Animals; Caspase 3; Dronabinol; Female; Hemagglutinins, Viral; Immunity, Innate; Inflammation; Influenza A virus; Lung; Mice; Mice, Inbred C57BL; Mucin 5AC; Mucins; RNA, Messenger | 2007 |
Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
Topics: Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dronabinol; Female; Flow Cytometry; Inflammation; Influenza A virus; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA; T-Lymphocytes | 2008 |
Marijuana, inflammation, and CT-3 (DMH-11C): cannabis leads to new class of antiinflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Dronabinol; Drugs, Investigational; Inflammation | 1998 |
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
Topics: Acute Disease; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Carrageenan; Disease Models, Animal; Dronabinol; Edema; Endocannabinoids; Ethanolamines; Hindlimb; Hyperalgesia; Indomethacin; Inflammation; Male; Motor Activity; Palmitic Acids; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2002 |